|
Pronunciation |
|
(par
oh moe MYE
sin) |
|
|
U.S. Brand
Names |
|
Humatin® |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Paromomycin Sulfate |
|
|
Pharmacological Index |
|
Amebicide |
|
|
Use |
|
Treatment of acute and chronic intestinal amebiasis; preoperatively to
suppress intestinal flora; tapeworm infestations; treatment of
Cryptosporidium |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Intestinal obstruction, renal failure, known hypersensitivity to paromomycin
or components |
|
|
Warnings/Precautions |
|
Use with caution in patients with impaired renal function or possible or
proven ulcerative bowel lesions |
|
|
Adverse
Reactions |
|
1% to 10%: Gastrointestinal: Diarrhea, abdominal cramps, nausea, vomiting,
heartburn
<1%: Headache, vertigo, exanthema, rash, pruritus, steatorrhea, secondary
enterocolitis, eosinophilia, ototoxicity |
|
|
Overdosage/Toxicology |
|
Symptoms of overdose include nausea, vomiting, diarrhea
Following GI decontamination, if possible; care is supportive and symptomatic
|
|
|
Drug
Interactions |
|
Decreased effect of digoxin, vitamin A, and methotrexate
Increased effect of oral anticoagulants, neuromuscular blockers, and
polypeptide antibiotics |
|
|
Mechanism of
Action |
|
Acts directly on ameba; has antibacterial activity against normal and
pathogenic organisms in the GI tract; interferes with bacterial protein
synthesis by binding to 30S ribosomal subunits |
|
|
Pharmacodynamics/Kinetics |
|
Absorption: Not absorbed via oral route
Elimination: 100% unchanged in feces |
|
|
Usual Dosage |
|
Oral:
Dientamoeba fragilis: Children and Adults: 25-30 mg/kg/day in 3
divided doses for 7 days
Cryptosporidium: Adults with AIDS: 1.5-2.25 g/day in 3-6 divided
doses for 10-14 days (occasionally courses of up to 4-8 weeks may be needed)
Tapeworm (fish, dog, bovine, porcine):
Children: 11 mg/kg every 15 minutes for 4 doses
Adults: 1 g every 15 minutes for 4 doses
Hepatic coma: Adults: 4 g/day in 2-4 divided doses for 5-6 days
Dwarf tapeworm: Children and Adults: 45 mg/kg/dose every day for 5-7 days
|
|
|
Dietary
Considerations |
|
Paromomycin may cause malabsorption of xylose, sucrose, and
fats |
|
|
Mental Health: Effects
on Mental Status |
|
May cause dizziness |
|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
None reported |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Take as directed, for full course of therapy. Do not skip doses. Maintain
adequate hydration (2-3 L/day of fluids unless instructed to restrict fluid
intake) and nutrition. If GI upset occurs, small frequent meals, frequent mouth
care, sucking lozenges, or chewing gum may help. Report unresolved or severe
nausea or vomiting, dizziness, ringing in ears, or loss of hearing.
Pregnancy precautions: Inform prescriber if you are
pregnant. |
|
|
Nursing
Implications |
|
Monitor hearing loss before and during therapy |
|
|
Dosage Forms |
|
Capsule, as sulfate: 250 mg |
|
|
References |
|
Danziger LH, Kanyok TP, and Novak RM,
"Treatment of Cryptosporidial Diarrhea in an AIDS Patient With Paromomycin,"
Ann Pharmacother, 1993, 27(12):1460-2.
"Drugs for Parasitic Infections," Med Lett Drugs Ther, 1998,
40(1017):1-12.
Liu LX and Weller PF, "Antiparasitic Drugs," N Engl J Med, 1996,
334(18):1178-84. |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|